Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Zuckerman

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Medical Virology|December 1, 1994
Hepatitis A antibodies in attenders of London Travel Clinics: cost-benefit of screening prior to hepatitis A immunisationJ N Zuckerman, L Powell
Journal of Hepatology|January 1, 1995
Prospects for hepatitis C vaccineA J Zuckerman, J N Zuckerman
Journal of Medical Virology|August 14, 1999
Molecular epidemiology of hepatitis B virus mutantsA J Zuckerman, J N Zuckerman
Journal of Medical Virology|August 13, 1998
Clinical implications of GB virus CI K Mushahwar, J N Zuckerman
The Journal of Infection|October 12, 2000
Current topics in hepatitis BJ N Zuckerman, A J Zuckerman
Lancet (London, England)|January 28, 1995
Acute hepatitis B infection after vaccinationJ N Zuckerman, A J Zuckerman
Journal of Travel Medicine|April 18, 2001
A survey of the profile and perceived value of a London Travel ClinicJ N Zuckerman, C Sabin, J Battersby
Journal of Travel Medicine|September 26, 2000
A study of the incidence of accidents occurring during an Arctic expedition: another important aspect of travel medicine?F J Cooke, C Sabin, J N Zuckerman
BMJ (Clinical Research Ed.)|November 7, 1992
Site of injection for vaccinationJ N Zuckerman, A Cockcroft, A J Zuckerman
Journal of Travel Medicine|October 17, 1998
Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL.U) as a booster following primary immunization with Havrix (1440 EL.U) against hepatitis AJ N Zuckerman, C T Kirkpatrick, M Huang
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Medical Virology|December 1, 1994
Hepatitis A antibodies in attenders of London Travel Clinics: cost-benefit of screening prior to hepatitis A immunisationJ N Zuckerman, L Powell
Journal of Hepatology|January 1, 1995
Prospects for hepatitis C vaccineA J Zuckerman, J N Zuckerman
Journal of Medical Virology|August 14, 1999
Molecular epidemiology of hepatitis B virus mutantsA J Zuckerman, J N Zuckerman
Journal of Medical Virology|August 13, 1998
Clinical implications of GB virus CI K Mushahwar, J N Zuckerman
The Journal of Infection|October 12, 2000
Current topics in hepatitis BJ N Zuckerman, A J Zuckerman
Lancet (London, England)|January 28, 1995
Acute hepatitis B infection after vaccinationJ N Zuckerman, A J Zuckerman
Journal of Travel Medicine|April 18, 2001
A survey of the profile and perceived value of a London Travel ClinicJ N Zuckerman, C Sabin, J Battersby
Journal of Travel Medicine|September 26, 2000
A study of the incidence of accidents occurring during an Arctic expedition: another important aspect of travel medicine?F J Cooke, C Sabin, J N Zuckerman
BMJ (Clinical Research Ed.)|November 7, 1992
Site of injection for vaccinationJ N Zuckerman, A Cockcroft, A J Zuckerman
Journal of Travel Medicine|October 17, 1998
Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL.U) as a booster following primary immunization with Havrix (1440 EL.U) against hepatitis AJ N Zuckerman, C T Kirkpatrick, M Huang
Pageof 4